Healthcare - Biotechnology - NASDAQ - US
$ 0.744
-3.7 %
$ 85.7 M
Market Cap
-8.27
P/E
CASH FLOW STATEMENT
-175 M
OPERATING CASH FLOW
145 M
INVESTING CASH FLOW
69.6 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Coherus BioSciences, Inc.
| Net Income | -238 M |
| Depreciation & Amortization | 3.79 M |
| Capital Expenditures | -286 K |
| Stock-Based Compensation | 43.1 M |
| Change in Working Capital | -36.8 M |
| Others | 190 M |
| Free Cash Flow | -175 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||||||||
| Net Income | (237.9) | (291.8) | (287.1) | 132.2 | 89.8 | (209.4) | (238.3) | (127.8) | (223.9) | (87.2) | (53.6) | (33.0) |
| Depreciation & Amortization | 3.8 | 3.7 | 3.5 | 2.9 | 3.3 | 3.2 | 3.4 | 3.0 | 1.9 | 0.7 | 0.4 | 0.2 |
| Deferred Income Tax | 0 | 0 | 9.4 | (0.2) | 55 K | 3.6 | 0.5 | (1.3) | 1.7 | 13.9 | 12.3 | (7.0) |
| Stock Based Compensation | 43.1 | 50.7 | 51.4 | 38.2 | 33.6 | 34.8 | 36.1 | 27.4 | 16.7 | 11.1 | 2.0 | 0.4 |
| Other Operating Activities | 52.9 | 75.5 | 143.1 | 6.0 | 15.7 | (1.7) | 3.2 | 5.3 | 4.6 | 9.2 | 12.9 | 9.5 |
| Change in Working Capital | (36.8) | (79.3) | 42.4 | (32.5) | (113.9) | 10.3 | (5.1) | (159.2) | 91.1 | 28.4 | 41.4 | 11.6 |
| Cash From Operations | (174.9) | (241.1) | (37.4) | 154.1 | 28.4 | (159.3) | (200.3) | (252.5) | (108.0) | (23.9) | 15.4 | (18.3) |
| INVESTING CASH FLOW | ||||||||||||
| Capital Expenditures | (0.3) | (2.0) | (1.3) | (7.1) | (12.9) | (0.8) | (4.6) | (6.5) | (6.2) | (2.8) | (0.4) | (1.8) |
| Other Items | 144.9 | (164.8) | (137.1) | (7.3) | 0.2 | (0.4) | 0.2 | 0 | (0.8) | 2.3 | 0 | 40 K |
| Cash From Investing Activities | 144.6 | (166.8) | (138.4) | (14.4) | (12.7) | (1.2) | (4.4) | (6.5) | (6.9) | (0.5) | (0.4) | (1.8) |
| FINANCING CASH FLOW | ||||||||||||
| Common Stock Repurchased | 0 | 0 | 0 | (0.9) | 0 | 0 | (0.5) | 0 | 0 | 2 K | 0 | 0 |
| Total Debt Repaid | 0 | 49.9 | 0 | 222.2 | 73.0 | 0 | 0 | 100.0 | 0 | 0 | 9.9 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (2.1) | (2.0) | 11.0 | 1.8 | 8.3 | 3.7 | 0.5 | 2.6 | (0.1) | 50.5 | 6 K | 26.9 |
| Cash From Financing Activities | 69.6 | 54.3 | 51.9 | 223.9 | 89.4 | 105.4 | 206.8 | 226.2 | 122.7 | 136.0 | 10.0 | 26.9 |
| CHANGE IN CASH | ||||||||||||
| Net Change In Cash | 39.4 | (353.6) | (124.0) | 363.7 | 104.7 | (54.6) | 2.0 | (33.3) | 7.8 | 110.8 | 25.0 | 6.9 |
| FREE CASH FLOW | ||||||||||||
| Free Cash Flow | (175.2) | (243.2) | (38.7) | 147.1 | 15.5 | (160.1) | (204.9) | (259.1) | (114.2) | (26.8) | 15.1 | (20.0) |